Saroja Pharma Industries India was originally incorporated as Private Limited, under the Companies Act, 2013 (Companies Act) in the name and style of ‘Saroja Pharma Industries India Private Limited’ on January 14, 2019 under the provisions of the Companies Act, 2013 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra. Later on, company was converted into public limited company and due to the conversion, the name of the company name was changed to ‘Saroja Pharma Industries India Limited’ and a fresh Certificate of Incorporation dated April 18, 2023 was issued by the Registrar of Companies, Mumbai, Maharashtra.
The company is amongst the leading traders, exporter and suppliers of Specialty Chemicals. The offered range is widely praised for its superior effectiveness, shelf life and perfect composition. The company was incorporated with the objective of the best service deliverance in chemical trading with the best premium pharmaceutical companies in India and abroad for cost effective human and veterinary medicine. The company trade in Pharma API, Pharma Intermediates, Chemicals, Solvents used for pharmaceutical products human and veterinary medicine. The Company was formed with a mission being providing clientele specification based approved product at a competitive pricing with hassle free dispatch within India or aboard contributing to cost effectiveness in end product for human and veterinary medicine.
The product demand by its clientele is manufactured as per their specifications by its suppliers initially in sample size thereafter on clients testing and approving the order is finalized. The approved specified product is manufactured for the order quantity to be dispatched by the appropriate mode of transport within India or abroad. Since its inception, Saroja Pharma Industries India has witnessed a substantial expansion in its clientele base over the past two years. This growth has propelled the company to venture into the manufacturing of API Pharma products, for veterinary use. By broadening its product portfolio, Saroja Pharma Industries India aims to provide a comprehensive range of pharmaceutical solutions that cater to the diverse needs of its expanding customer base. This strategic move not only enhances the company's value proposition but also reinforces its commitment to delivering affordable healthcare solutions globally.
Business area of the company
The company is engaged into the business of trading of pharma products like pharma API, Pharma Intermediary and Pharma chemicals.
Products of the company
Chemical
- Liquid bromine
- Ethyl acetate
- Thionyl chloride
- Para nitro phenol
- Toluene N.G
- Benzyl chloride
Active Pharmaceutical Ingredient (API)
- Oxyclozanide BP Vet
- Bromhexine HCL BP Grade
- Triclabendazole
- Fenbendazole BP Vet
- Nitroxynil BP Vet
- Oxfendazole BP Vet
- Albendazole USP
- Rafoxanide BP Vet
- Febantel EP
Pharma Intermediary
History and milestones
- 2019: Incorporation of the company viz. Saroja Pharma Industries India Private Limited.
- 2023: Conversion of the company’s status from Private Limited to Limited Company to Saroja Pharma Industries India Limited.